Praneetha Thulasi is an Ophthalmology physician affiliated with Washington University in St. Louis. OpenAlex indexes 58 publications with 843 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4901 Forest Park Ave
Dept Ophthalmology, 6th Fl
Saint Louis, MO 631081495
Telephone
314-362-3937Provider last certified this registry record 19 Sept 2025.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Bausch & Lomb Americas Inc.Program year20251 payment
- Alcon Vision LLCProgram year20243 payments
- Oyster Point Pharma, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
53.1%Corticosteroid36.5%Prednisolone Acetate83%Fluorometholone17%Part D≥333 patientsCorticosteroids, plain4.3%Loteprednol Etabonate62%Lotemax23%Lotemax Sm15%Part D<11 patients+ 6 more classes in this area
Anti-infectives
34%Fluoroquinolone Antibacterial23%Moxifloxacin100%Part D≥267 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor6.6%Valacyclovir100%Part D≥51 patients+ 2 more classes in this area
Musculoskeletal
6%Cyclooxygenase Inhibitor6%Ketorolac Tromethamine100%Part D≥101 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Effect of Rho Kinase Inhibitors on Corneal Transplant Survival in Patients Treated for Glaucoma
Eye Banking and Corneal Transplantation
2026 - Effect of Netarsudil 0.02% on a Patient with Fuchs Corneal Dystrophy and Radial Keratotomy
Journal of Clinical & Translational Ophthalmology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Timothy Ley, MD
Washington University in St. Louis
David Gutmann, MD
Washington University in St. Louis
Randall Bateman, MD
Washington University in St. Louis
Victoria Fraser, MD
Washington University in St. Louis
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”